Cited by 185Sleep and Wakefulness ResearchTraumatic Brain Injury and Neurovascular DisturbancesTraumatic Brain Injury Research

Loss of hypocretin (orexin) neurons with traumatic brain injury

Open access
Baumann, Christian R., Bassetti, Claudio L., Valko, Philipp O., Haybaeck, Johannes, Keller, Morten, Clark, Erika, Stocker, Reto, Tolnay, Markus +1 more·2009·Annals of Neurology

Abstract

Chronic, daytime sleepiness is a major, disabling symptom for many patients with traumatic brain injury (TBI), but thus far, its etiology is not well understood. Extensive loss of the hypothalamic neurons that produce the wake‐promoting neuropeptide hypocretin (orexin) causes the severe sleepiness of narcolepsy, and partial loss of these cells may contribute to the sleepiness of Parkinson disease and other disorders. We have found that the number of hypocretin neurons is significantly reduced in patients with severe TBI. This observation highlights the often overlooked hypothalamic injury in TBI and provides new insights into the causes of chronic sleepiness in patients with TBI. Ann Neurol 2009;66:555–559

AI snapshot

Written from the paper’s full text.

TL;DR

In postmortem hypothalami from 4 patients with severe TBI versus 4 controls, hypocretin neuron number was significantly reduced by 27%. This suggests that hypothalamic hypocretin neuron loss may contribute to chronic sleepiness after TBI.

Key findings

  • TBI subjects had 27% fewer hypocretin neurons than controls (23,655 ± 5,035 vs. 32,318 ± 3,060 neurons, p = 0.001).
  • MCH neurons were 31% fewer in TBI subjects (39,540 ± 10,900 vs. 57,176 ± 24,016), but this was not quite statistically significant (p = 0.06); excluding one female control with low MCH neuron numbers, TBI subjects had 29% fewer hypocretin neurons (p = 0.002) and 40% fewer MCH neurons (p = 0.003).
  • GFAP-labeled astrocyte density was higher in TBI patients than controls (21 ± 12 vs. 7 ± 2 per mm², p < 0.001), and patients with more severe hypocretin neuron loss had more GFAP-labeled astrocytes (r = −0.46, p = 0.01).
  • TBI hypothalami also showed intense perivascular hypocretin immunoreactivity, and many hypocretin neurons were small and pyknotic with reduced hypocretin fiber density.

Methods

  • Autopsy brains from 4 patients who died 7 to 42 days (mean 19) after severe TBI and 4 control subjects with no clinical evidence of TBI or other neurological disorders; TBI patients were younger (51 ± 19 years) than controls (69 ± 18 years), and all subjects were male except one woman in the control group.
  • Immunohistochemistry for hypocretin-1, MCH, and GFAP; hypocretin and MCH neurons were counted across a 1:24 series of the entire hypothalamus with Abercrombie correction, and GFAP-immunolabeled astrocytes were counted in 30 randomly selected 400 by 400 µm sites within the lateral and posterior hypothalamus.
  • Cell counts were compared between groups using Student’s t-tests.

Limitations

  • Stated by the paper: the study examined a small number of brains, control subjects were not fully matched, other wake-promoting systems were not examined, and the patients had fatal TBI, probably introducing selection bias; non-fatal TBI may be associated with less severe hypocretin neuron loss.
  • Evident from the text: this is described as a pilot study with severe/fatal TBI cases, so findings may not generalize to milder or non-fatal TBI, and the autopsy design cannot directly establish that hypocretin loss causes chronic sleepiness.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/ana.21836

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

16 of 32 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Injury to ascending arousal pathways from the brainstem may contribute to chronic sleepiness after head trauma.

    “Injury to ascending arousal pathways from the brainstem may contribute, but recent findings suggest a key role for the neuropeptides hypocretin-1 and -2 (also known as orexin-A and -B).2,4,5”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [2] Baumann CR Werth E Stocker R Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study Brain 2007 130 1873 1883 17584779 source

      The section on clinical characteristics and potential causes proposes that TBI may damage hypocretin neurons or their axons, contributing to post-traumatic sleepiness. It does not identify injury to ascending arousal pathways from the brainstem as that mechanism. The risk-factors section reports no association between lesion location and sleep-wake disturbances; outcomes in patients with visible brainstem or hypothalamic lesions did not differ from those of other patients. Page numbers were not available in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [4] Baumann CR Stocker R Imhof HG Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury Neurology 2005 65 147 149 16009905 source
    • cites [5] España RA Scammell TE Sleep neurobiology for the clinician Sleep 2004 27 811 820 15283019 source

      The review’s Arousal Network section says lesions of the rostral reticular formation can disrupt wakefulness because they also damage arousal fibers. Its introductory discussion reports excessive sleepiness after injury to wake-promoting regions, but it does not establish that brainstem pathway injury contributes to chronic sleepiness specifically after head trauma. Page numbers are unavailable in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Premisecitation

    Even after 6 months recovery, many TBI patients with EDS have persistently low hypocretin-1 levels.

    “Even after 6 months recovery, many TBI patients with EDS have persistently low hypocretin-1 levels.2”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [2] Baumann CR Werth E Stocker R Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study Brain 2007 130 1873 1883 17584779 source

      The Laboratory studies section reports that hypocretin-1 remained low in 4 of 21 patients at six months, while it was normal in 17. The Clinical characteristics section says levels were lower in patients with EDS, but does not establish that many patients with EDS had persistently low levels. The claim overstates the prevalence of persistent deficiency. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    Selective loss of hypocretin-producing neurons causes sleepiness and cataplexy in over 90% of patients with narcolepsy.

    “Selective loss of the hypocretin-producing neurons causes sleepiness and cataplexy in over 90% of patients with narcolepsy,5–9”
    Quote in the paperSubstantial claim2 of 5 sources checked
    • cites [5] España RA Scammell TE Sleep neurobiology for the clinician Sleep 2004 27 811 820 15283019 source

      The Orexin/Hypocretin section (page unavailable) links loss of orexin neurons to difficulty maintaining wakefulness and describes cataplexy with deficient orexin signaling. But its figure is about 90% of patients with narcolepsy *and cataplexy* having undetectable cerebrospinal-fluid orexin—not over 90% of all patients with narcolepsy having selective neuronal loss that causes both symptoms. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [6] Adamantidis AR Zhang F Aravanis AM Neural substrates of awakening probed with optogenetic control of hypocretin neurons Nature 2007 450 420 424 17943086 PMC6744371 source
    • cites [7] Peyron C Faraco J Rogers W A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 2000 6 991 997 10973318 source
    • cites [8] Thannickal TC Moore RY Nienhuis R Reduced number of hypocretin neurons in human narcolepsy Neuron 2000 27 469 474 11055430 PMC8760623 source
    • cites [9] Crocker A España RA Papadopoulou M Concomitant loss of dynorphin, NARP, and orexin in narcolepsy Neurology 2005 65 1184 1188 16247044 PMC2254145 source

      The Conclusions (page unavailable) say that narcolepsy with cataplexy is likely caused by loss of orexin-producing neurons, and the Discussion links disrupted orexin signaling to sleepiness and cataplexy. The paper does not establish that this occurs in over 90% of patients: its Results report roughly 90% or greater neuron loss in two people with narcolepsy and cataplexy, not a percentage of patients. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Premisecitation

    Even after 6 months recovery, 43% of patients have symptoms of sleep disorders.

    “Coma and obtundation are common during the acute period, but even after 6 months recovery, 43% of patients have symptoms of sleep disorders.2,3”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [2] Baumann CR Werth E Stocker R Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study Brain 2007 130 1873 1883 17584779 source

      The Fig. 3 caption (Single patient reports; page unavailable) reports that 28 of 65 patients (43%) had sleep–wake disturbances for which no cause other than traumatic brain injury was identified. But it reports sleep–wake disturbances in 47 of 65 patients overall, so 43% is the rate for a narrower group, not the overall rate implied by the claim. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [3] Castriotta RJ Wilde MC Lai JM Prevalence and consequences of sleep disorders in traumatic brain injury J Clin Sleep Med 2007 3 349 356 17694722 PMC1978308 source

      The Discussion reports that 47% of the TBI sample had a diagnosed sleep disorder, and Table 4 includes patients studied more than six months after injury. It does not report that 43% had symptoms after six months of recovery; the stated percentage, measure, and time-specific estimate are unsupported. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Findingown data

    Patients with more severe loss of hypocretin neurons had more GFAP-labeled astrocytes (r=−0.46, p=0.01).

    “Double immunofluorescence staining showed that patients with more severe loss of hypocretin neurons had more GFAP-labeled astrocytes (r=−0.46, p=0.01).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. 17
  • May combine two claims. 14
  • Classified as probably not a substantial claim.

    Premisecitation

    Identical symptoms occur in mice genetically lacking hypocretins.

    “and identical symptoms occur in mice genetically lacking hypocretins.10”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [10] Chemelli RM Willie JT Sinton CM Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 1999 98 437 451 10481909 source

      The Discussion reports that mice lacking orexin (hypocretin) have narcoleptic attacks and sleep dysregulation remarkably similar to human narcolepsy. It does not establish that the symptoms are identical: the authors say they cannot clearly distinguish the mice’s narcoleptic from cataplectic episodes and note an EEG feature not reported in humans or dogs. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Chronic daytime sleepiness is a major disabling symptom for many patients with TBI, and its etiology is not well understood.

    “Chronic, daytime sleepiness is a major, disabling symptom for many patients with traumatic brain injury (TBI), but thus far, its etiology is not well understood.”
    • Also stated in: § Introduction · plain
      “Though chronic sleepiness is common after head trauma, the cause remains unclear.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [2] Baumann CR Werth E Stocker R Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study Brain 2007 130 1873 1883 17584779 source
    • cites [3] Castriotta RJ Wilde MC Lai JM Prevalence and consequences of sleep disorders in traumatic brain injury J Clin Sleep Med 2007 3 349 356 17694722 PMC1978308 source

      The Discussion reports a high prevalence of excessive daytime sleepiness after TBI and poorer cognitive and vigilance performance in sleepy subjects. It says functional disability is possible but that the impact on day-to-day functioning has not been established; it also cannot determine whether some sleep disorders preceded the injury. The paper therefore supports the prevalence and uncertainty about cause, but not the stronger claim that chronic sleepiness is an established major disabling symptom. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In a prospective study of 65 TBI patients, 1 in 4 patients reported excessive daytime sleepiness irrespective of the location or severity of the head trauma.

    “In a prospective study of 65 TBI patients, 1 in 4 patients reported excessive daytime sleepiness (EDS) irrespective of the location or severity of the head trauma.2”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [2] Baumann CR Werth E Stocker R Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study Brain 2007 130 1873 1883 17584779 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In another study of 87 patients, sleepiness occurred in 25% after TBI.

    “Another study of 87 patients revealed similar results, with sleepiness in 25% after TBI.3”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [3] Castriotta RJ Wilde MC Lai JM Prevalence and consequences of sleep disorders in traumatic brain injury J Clin Sleep Med 2007 3 349 356 17694722 PMC1978308 source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Hypocretins are made by a small cluster of neurons in the lateral hypothalamus that play an essential role in promoting wakefulness.

    “Hypocretins are made by a small cluster of neurons in the lateral hypothalamus that play an essential role in promoting wakefulness.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [5] España RA Scammell TE Sleep neurobiology for the clinician Sleep 2004 27 811 820 15283019 source

      The Orexin/Hypocretin section says hypocretins are produced by neurons in the lateral and posterior hypothalamus and that these neurons play an essential role in stabilizing wakefulness. It does not establish that they form a small cluster, and it names the posterior hypothalamus as well as the lateral hypothalamus. (LLM, conf=0.79)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Study design and conductcitation

    In controls, the total number of hypocretin neurons and their distribution across the lateral and posterior hypothalamus were similar to prior reports.

    “In controls, the total number of hypocretin neurons and their distribution across the lateral and posterior hypothalamus were similar to prior reports.7,8,14,15”
    Quote in the paperNot a substantial claim2 of 4 sources checked
    • cites [7] Peyron C Faraco J Rogers W A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 2000 6 991 997 10973318 source
    • cites [8] Thannickal TC Moore RY Nienhuis R Reduced number of hypocretin neurons in human narcolepsy Neuron 2000 27 469 474 11055430 PMC8760623 source
    • cites [14] Fronczek R Overeem S Lee SY Hypocretin (orexin) loss in Parkinson's disease Brain 2007 130 1577 1585 17470494 source

      The Hypocretin-1 cell number section reports a control median of 36,842 neurons, and the Hypocretin-1 histochemistry section says their distribution matched an earlier description in the perifornical lateral hypothalamus. Our copy does not compare the control total with prior reports or explicitly describe a distribution across both the lateral and posterior hypothalamus. Page numbers were not available in the indexed passages. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [15] Thannickal TC Lai YY Siegel JM Hypocretin (orexin) cell loss in Parkinson's disease Brain 2007 130 1586 1595 17491094 PMC8762453 source

      The Materials and methods and Quantitative analysis sections say the authors examined five normal brains and determined hypocretin-cell number and distribution. The passages available from our copy do not give a total control-neuron count or say that the count and lateral/posterior hypothalamic distribution were similar to prior reports (pages not provided). (LLM, conf=0.70)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Other reports describe pituitary and hypothalamic dysfunction after TBI.

    “Other reports describe pituitary and hypothalamic dysfunction,17,18”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [17] Karavitaki N Wass J Henderson Slater JD Wade D A case of post-traumatic isolated ACTH deficiency with spontaneous recovery 9 months after the event J Neurol Neurosurg Psychiatry 2006 77 276 277 16421141 PMC2077606 source

      The case report describes isolated ACTH deficiency after traumatic brain injury, supporting pituitary dysfunction. The Discussion mentions the hypothalamus as a possible site of injury but does not report hypothalamic dysfunction; page numbers are unavailable in our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [18] Schneider HJ Aimaretti G Kreitschmann-Andermahr I Hypopituitarism Lancet 2007 369 1461 1470 17467517 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    The pattern of gliosis differed across the TBI patients.

    “The pattern of gliosis differed across the TBI patients.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Many hypocretin neurons in TBI patients were small and pyknotic, and the density of hypocretin fibers appeared reduced.

    “Many hypocretin neurons in TBI patients were small and pyknotic, and the density of hypocretin fibers appeared reduced.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Among TBI patients, the number of hypocretin neurons differed moderately between the left and right sides of the hypothalamus and between individuals.

    “Among the TBI patients, the number of hypocretin neurons differed moderately between the left and right sides of the hypothalamus and between individuals, reflecting the asymmetry and heterogeneity of TBI.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The TBI patients had significantly fewer hypocretin neurons even though they were younger than the controls.

    “However, our TBI patients had significantly fewer hypocretin neurons even though they were younger than the controls.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    TBI patients had 31% fewer MCH neurons than controls (39,540±10,900 vs. 57,176±24,016), but this reduction was not quite statistically significant (p = 0.06).

    “TBI patients also had 31% fewer MCH neurons than controls (39,540±10,900 vs. 57,176±24,016), but this reduction was not quite statistically significant (p = 0.06), probably because of variable numbers of MCH neurons.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Excluding the female control subject with surprisingly low numbers of MCH neurons, TBI subjects had 29% fewer hypocretin neurons than controls (33,342±2,785; p=0.002) and 40% fewer MCH neurons (66,434±18,730; p=0.003).

    “If one excludes the female control subject with surprisingly low numbers of MCH neurons (control subject 2), then the TBI subjects had 29% fewer hypocretin neurons than controls (33,342±2,785; p=0.002) and 40% fewer MCH neurons (66,434±18,730; p=0.003).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    The perivascular staining may represent phagocytized hypocretin peptide following damage to the hypocretin neurons.

    “The perivascular staining may represent phagocytized hypocretin peptide following damage to the hypocretin neurons.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The study did not examine other wake-promoting systems.

    “In addition, we did not examine other wake-promoting systems, and the extent of injury to other arousal pathways should be further investigated in larger human and animal studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The study examined a small number of brains, and the control subjects were not fully matched.

    “We examined a small number of brains, and the control subjects were not fully matched.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    One early study showed damage to the hypothalamus in 42% of deceased TBI patients.

    “One early study showed damage to the hypothalamus in 42% of deceased TBI patients.11”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [11] Crompton MR Hypothalamic lesions following closed head injury Brain 1971 94 165 172 5552160 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    TBI patients were younger (51 ± 19 years) than controls (69 ± 18 years), and all subjects were male except for one woman in the control group.

    “In this pilot study, the TBI patients were younger (51 ± 19 years) than the controls (69 ± 18 years), and all subjects were male except for one woman in the control group.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    Abercrombie corrections based on the size of cell nuclei in each subject were performed to estimate numbers of hypocretin and MCH neurons.

    “To estimate accurately the numbers of hypocretin and MCH neurons in each section, we performed Abercrombie corrections based on the size of the cell nuclei in each subject.13”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [13] Guillery RW On counting and counting errors J Comp Neurol 2002 447 1 7 11967890 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Postmortem delays were similar in both groups (TBI: 12±3 hours, controls: 13±3 hours).

    “Postmortem delays were similar in both groups (TBI: 12±3 hours, controls: 13±3 hours) (Supplemental Table).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    Only clearly immunolabeled neurons with neuronal morphology, outgoing axons and dendrites, and a nuclear void were counted.

    “Only clearly-immunolabeled neurons with neuronal morphology, outgoing axons and dendrites, and a nuclear void were counted.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    TBI injury was not limited to hypocretin neurons as there was a partial loss of neurons producing MCH and patchy gliosis throughout the hypothalamus.

    “This injury was not limited to the hypocretin neurons as there was a partial loss of neurons producing MCH and patchy gliosis throughout the hypothalamus.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning

    Non-fatal TBI may be associated with a less severe loss of hypocretin neurons.

    “It is possible that non-fatal TBI is associated with a less severe loss of hypocretin neurons.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A fine-scale counting grid encompassing no more than 10 neurons per grid sector was used to prevent miscounting.

    “To prevent miscounting, we used a fine-scale counting grid that encompassed no more than 10 neurons per grid sector.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Hypersomnolence is common with hypothalamic and rostral brainstem injuries, but is uncommon with selective loss of the hypocretin neurons.

    “Hypersomnolence is common with hypothalamic and rostral brainstem injuries, but is uncommon with selective loss of the hypocretin neurons.21”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [21] Scammell TE Culebras A Secondary Narcolepsy Sleep Disorders and Neurologic Diseases 2007 2nd edition New York Informa Healthcare 117 134

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Premisecitation

    About one-third of TBI patients have brainstem injuries, often near the midbrain tegmentum, that may disrupt ascending monoaminergic or cholinergic wake-promoting pathways.

    “About one-third of TBI patients have brainstem injuries, often near the midbrain tegmentum, that may disrupt ascending monoaminergic or cholinergic wake-promoting pathways.20”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] Crompton MR Brainstem lesions due to closed head injury Lancet 1971 1 669 673 4101614 source
  • May combine two claims.

    Study design and conductown data

    The normal distribution of hypocretin neurons in TBI brains demonstrates the reliability and completeness of the cell counts.

    “Though TBI brains contained fewer hypocretin neurons, the neurons were distributed in a normal pattern, thus demonstrating the reliability and completeness of the cell counts (Figure 2).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    In all subjects, the complete hypocretin neuron field was examined.

    “In all subjects, the complete hypocretin neuron field was examined (Supplemental Figure A).”
    Quote in the paperSubstantial claim
28 of 28
  • The authors state this as an assumption.

    Partial loss of hypocretin neurons causes the generally milder sleepiness of narcolepsy without cataplexy and Parkinson's disease.

    “some hypothesize that a partial loss of these cells causes the generally milder sleepiness of narcolepsy without cataplexy and Parkinson’s disease.14,15,19”
    “This assumption is supported by our recent finding of reduced CSF hypocretin-1 levels in sleepy TBI patients who survived their injury.2”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Baumann et al. 2009, the number of hypocretin neurons was decreased by 27% compared to controls in 4 TBI patients.

    “Baumann et al. 2009 found that in 4 TBI patients, the number of hypocretin neurons was decreased by 27% compared to controls.47”
  • Some studies have evidence of reduced numbers of MCH neurons after injury, observed after severe TBI.

    “some studies have evidence of reduced numbers of MCH neurons after injury. However, this outcome was observed after severe TBI,46,47”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Baumann, C. R., Bassetti, C. L., Valko, P. O., Haybaeck, J., Keller, M., Clark, E., Stocker, R., Tolnay, M., & Scammell, T. E.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • University Hospital Zurich (CH)
Corresponding author
Baumann, Christian R.
Venue
Annals of Neurology
Publisher
Wiley
Published
2009-10
Volume
66
Issue
4
Pages
555-559
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2025705478
Cited by
185
References
25
Citations by year
2026: 2 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 13 · 2021: 10 · 2020: 13 · 2019: 11 · 2018: 22 · 2017: 10 · 2016: 10 · 2015: 19 · 2014: 12 · 2013: 10 · 2012: 12
FWCI
5.33
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • PubMed Central (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
National Institute of Mental Health (R01 MH062589, MH062589)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
Keywords
orexin, traumatic brain injury, hypothalamic neurons, narcolepsy, Parkinson's disease, wakefulness
MeSH terms
Orexins, Adult, Aged, Aged, 80 and over, Brain Injuries, Cell Count, Female, Humans, Hypothalamus, Male, Middle Aged, Neurons, Neuropeptides, Pilot Projects, Wakefulness, Intracellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-14.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-14.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review